Emergent BioSolutions (EBS) Tops Q3 EPS by 32c; Says FY16 Outlook Still Postponed

Go back to Emergent BioSolutions (EBS) Tops Q3 EPS by 32c; Says FY16 Outlook Still Postponed
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 6.55 -0.25 (3.68%)
Previous Close $6.80    52 Week High $44.38 
Open $6.80    52 Week Low $24.47 
Day High $6.90    P/E 327.50 
Day Low $6.48    EPS $0.02 
Volume 1,512,574